Good morning, everyone, and how are you today? We are doing just fine, thank you, especially as a shiny sun and deliciously cool breeze are enveloping the unusually quiet Pharmalot campus. One short person is off to work, the other is sleeping in, and our official mascot is snoozing somewhere on the premises. We hear the heavy breathing. As for us, we are brewing more cups of stimulation — butter pecan is the choice today, for those keeping track — and we invite you to join us. Now, though, time to get cracking. Here are a few items of interest to help you on your journey. And may it be a good one. Talk soon. …
The deal between Pfizer (PFE) and Mylan (MYL) may provide a big payday for Mylan chief executive Heather Bresch, the Pittsburgh Post-Gazette notes. Under terms of her contract described in Securities and Exchange Commission filings, if Bresch meets the terms, she is in line to receive severance equal to three times her $1.3 million base salary and the highest bonus she had been paid, which amounts to $18.6 million in cash. And she will pick up vested benefits, estimated at $19 million at the end of last year, for a total of $37.5 million.
About the Author Reprints
